GSK files shingles vaccine in EUShingrix has billion dollar sales potential, according to analysts. Share XGSK files shingles vaccine in EUhttps://pharmaphorum.com/news/gsk-files-shingles-vaccine-eu/
GSK files shingles vaccine in USShingrix has blockbuster potential, according to analysts. Share XGSK files shingles vaccine in UShttps://pharmaphorum.com/news/gsk-files-shingles-vaccine-us/